NIH to evaluate remdesivir treatment for COVID during pregnancy

Por um escritor misterioso

Descrição

WASHINGTON (NEWS10) — The National Institutes of Health (NIH) is funding a study into the effects of prescription remdesivir on those who are both pregnant and COVID-positive. Called “IMPAACT 2032,” the study, conducted at 17 sites in the U.S., will examine how pregnant people metabolize and digest the drug, and whether it poses side effects. […]
NIH to evaluate remdesivir treatment for COVID during pregnancy
Study will evaluate remdesivir for COVID-19 in pregnant women
NIH to evaluate remdesivir treatment for COVID during pregnancy
Therapeutic Management of Nonhospitalized Adults With COVID-19
NIH to evaluate remdesivir treatment for COVID during pregnancy
COVID-19 in people with rheumatic diseases: risks, outcomes
NIH to evaluate remdesivir treatment for COVID during pregnancy
Patients, Families, and Communities COVID-19 Impact Assessment
NIH to evaluate remdesivir treatment for COVID during pregnancy
Management of moderate severity outpatients with COVID‐19 disease
NIH to evaluate remdesivir treatment for COVID during pregnancy
Management Strategies in Children and Adolescents with Mild to
NIH to evaluate remdesivir treatment for COVID during pregnancy
Covid-19 Research Opens to Little-Studied Group: Pregnant Patients
NIH to evaluate remdesivir treatment for COVID during pregnancy
Monoclonal Antibody
NIH to evaluate remdesivir treatment for COVID during pregnancy
Remdesivir: A Review of Its Discovery and Development Leading to
NIH to evaluate remdesivir treatment for COVID during pregnancy
Management of Patients With COVID-19
de por adulto (o preço varia de acordo com o tamanho do grupo)